Shoshana Shendelman

Last updated

Shoshana Shendelman
Alma mater Columbia University
Known forFounder of Applied Therapeutics
Website https://drshendelman.com/

Shoshana Shendelman is an American scientist and founder of several biotech companies. [1] As of March 2025, Shendelman is the president of the biotech firms Retension Pharmaceuticals and Response Pharmaceuticals. [2]

Contents

Education

Shendelman obtained a BA in biochemistry from Brandeis University and an MA, MSc, and a PhD from the Columbia University College of Physicians and Surgeons where she wrote her dissertation on the molecular mechanisms of Parkinson’s Disease. [3]

Career

In 2008, Shendelman founded the life sciences consulting firm Clearpoint Strategy Group where she served as managing director for six years. [4] In 2016, Shendelman founded Applied Therapeutics, a biopharmaceutical company dedicated to creating treatments for rare diseases. [5] In 2024, Shendelman left the company after shareholders filed a class action lawsuit against her alleging securities fraud. [6] [7] [8]

In 2023, Shendelman joined the Trustees of Columbia University in the City of New York. [9]

References

  1. ↑ "Shoshana Shendelman". Forbes. Retrieved July 7, 2025.
  2. ↑ "Shoshana Shendelman | Office of the Secretary". secretary.columbia.edu. Retrieved July 7, 2025.
  3. ↑ "Shoshana Shendelman | Office of the Secretary". secretary.columbia.edu. Retrieved July 7, 2025.
  4. ↑ "Kikka Hanazawa and Shoshana Shendelman Join Trustees | Columbia Magazine". magazine.columbia.edu. Retrieved July 7, 2025.
  5. ↑ Gilson, Grace (July 2, 2025). "House committee says acting Columbia president Claire Shipman suggested the ouster of a Jewish trustee". Jewish Telegraphic Agency. Retrieved July 8, 2025.
  6. ↑ Walton, Meghnad Bose, Lara-Nour (May 27, 2025). "Columbia Trustee Got Sued for Securities Fraud — Then Left Her Pharma Firm Under a Cloud". The Intercept. Retrieved July 7, 2025.{{cite web}}: CS1 maint: multiple names: authors list (link)
  7. ↑ Incorvaia, Darren (December 20, 2024). "After investors file lawsuit, Applied CEO steps down". www.fiercebiotech.com. Retrieved July 7, 2025.
  8. ↑ Feuerstein, Adam (December 5, 2024). "Why Applied Therapeutics has a credibility problem". STAT. Retrieved July 8, 2025.
  9. ↑ Pickering, Emily. "Trustee Shoshana Shendelman, VP&S '03, '04, '05, files to dismiss securities fraud lawsuit over her pharmaceutical company". Columbia Daily Spectator. Retrieved July 7, 2025.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.